BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 17884351)

  • 1. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
    Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
    Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auditory mismatch negativity deficits in long-term heavy cannabis users.
    Roser P; Della B; Norra C; Uhl I; Brüne M; Juckel G
    Eur Arch Psychiatry Clin Neurosci; 2010 Sep; 260(6):491-8. PubMed ID: 20127103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of Δ
    Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
    Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
    Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
    Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
    Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of NMDA receptor antagonist memantine on mismatch negativity.
    Korostenskaja M; Nikulin VV; Kicić D; Nikulina AV; Kähkönen S
    Brain Res Bull; 2007 May; 72(4-6):275-83. PubMed ID: 17452287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
    Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
    Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
    Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of visual task difficulty and attentional direction on the detection of acoustic change as indexed by the Mismatch Negativity.
    Muller-Gass A; Stelmack RM; Campbell KB
    Brain Res; 2006 Mar; 1078(1):112-30. PubMed ID: 16497283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
    Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
    JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch negativity in tobacco-naïve cannabis users and its alteration with acute nicotine administration.
    Impey D; El-Marj N; Parks A; Choueiry J; Fisher D; Knott VJ
    Pharmacol Biochem Behav; 2015 Sep; 136():73-81. PubMed ID: 26188167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.
    Morgan CJA; Freeman TP; Hindocha C; Schafer G; Gardner C; Curran HV
    Transl Psychiatry; 2018 Sep; 8(1):181. PubMed ID: 30185793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
    Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
    Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans.
    de la Salle S; Inyang L; Impey D; Smith D; Choueiry J; Nelson R; Heera J; Baddeley A; Ilivitsky V; Knott V
    Pharmacol Biochem Behav; 2019 Sep; 184():172739. PubMed ID: 31283908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
    Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine and the hallucinating brain: effects on mismatch negativity (MMN) in schizophrenia.
    Fisher DJ; Grant B; Smith DM; Borracci G; Labelle A; Knott VJ
    Psychiatry Res; 2012 Apr; 196(2-3):181-7. PubMed ID: 22425471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.
    Winton-Brown TT; Allen P; Bhattacharyya S; Borgwardt SJ; Fusar-Poli P; Crippa JA; Seal ML; Martin-Santos R; Ffytche D; Zuardi AW; Atakan Z; McGuire PK
    Neuropsychopharmacology; 2011 Jun; 36(7):1340-8. PubMed ID: 21412224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of glycine on auditory mismatch negativity in schizophrenia.
    Greenwood LM; Leung S; Michie PT; Green A; Nathan PJ; Fitzgerald P; Johnston P; Solowij N; Kulkarni J; Croft RJ
    Schizophr Res; 2018 Jan; 191():61-69. PubMed ID: 28602646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
    Bhattacharyya S; Fusar-Poli P; Borgwardt S; Martin-Santos R; Nosarti C; O'Carroll C; Allen P; Seal ML; Fletcher PC; Crippa JA; Giampietro V; Mechelli A; Atakan Z; McGuire P
    Arch Gen Psychiatry; 2009 Apr; 66(4):442-51. PubMed ID: 19349314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.